AVIBACTAM

DRUG3 trials

Sponsors

Hellenic Institute For The Study Of Sepsis, Assistance Publique Hopitaux De Paris, Pfizer

Conditions

HealthySevere infectionsantibiotic therapy in Sepsis

Phase 1

A Study to Assess the Levels of Two Antibiotics in the Blood When Given Together and Separately

CompletedNCT01430910

Start: 2011-09-30End: 2012-10-31Updated: 2017-09-01

Phase 3

A RANDOMIZED PROSPECTIVE CLINICAL TRIAL TO ASSESS PROCALCITONIN-GUIDANCE AND MOLECULAR-GUIDED DIAGNOSIS AS MAINSTAY FOR THERAPY OF SEVERE INFECTIONS (The MODIFY trial)

Active, not recruitingCTIS2022-502962-26-00

Hellenic Institute For The Study Of SepsisSevere infections

Start: 2023-09-14Target: 190Updated: 2025-11-03

BICCS - Beta-lactam Intermittent versus Continuous infusion and Combination antibiotic therapy in Sepsis

Not yet recruitingCTIS2024-516849-39-01

Assistance Publique Hopitaux De Parisantibiotic therapy in Sepsis

Target: 600Updated: 2025-12-02

Related Papers

Randomized pharmacokinetic and drug–drug interaction studies of ceftazidime, avibactam, and metronidazole in healthy subjects

Pharmacology Research & Perspectives2015-08-2542 citations